anti il 6 capture antibody Search Results


90
Becton Dickinson rat-anti-il-6
Wnt5a is critical for gp120 to induce <t>IL-1β,</t> <t>IL-6,</t> and TNF-α in the SDH. A–C, time courses of IL-1β (A), IL-6 (B), and TNF-α (C) protein levels after i.t. gp120 (100 ng) administration. D–F, inhibition of Wnt5a by Box5 impaired gp120-induced increase of IL-1β (D), IL-6 (E), and TNF-α (F) protein in the SDH at 12 h after gp120 injection. G–I, sFRP3 attenuated gp120-induced increase of IL-1β (G), IL-6 (H), and TNF-α (I) protein levels in the SDH at 12 h after gp120 injection. Box5 (10 μg), sFRP3 (2 μg) or vehicle was intrathecally administered 30 min prior to 100 ng of gp120 or vehicle injection. In summary graphs, the levels of target proteins were normalized against β-actin and expressed as relative units to the control (0 h or vehicle). Data presented in graphs are means ± S.E. from at least 3 mice per group from three experiments. *, p < 0.05; **, p < 0.01 versus control (one way ANOVA).
Rat Anti Il 6, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+il+6+capture+antibody/pmc03650396-143-27-32?v=Becton+Dickinson
Average 90 stars, based on 1 article reviews
rat-anti-il-6 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
Corning Life Sciences capture monoclonal anti-murine il-6 antibody (clone mp5-20f3)
Wnt5a is critical for gp120 to induce <t>IL-1β,</t> <t>IL-6,</t> and TNF-α in the SDH. A–C, time courses of IL-1β (A), IL-6 (B), and TNF-α (C) protein levels after i.t. gp120 (100 ng) administration. D–F, inhibition of Wnt5a by Box5 impaired gp120-induced increase of IL-1β (D), IL-6 (E), and TNF-α (F) protein in the SDH at 12 h after gp120 injection. G–I, sFRP3 attenuated gp120-induced increase of IL-1β (G), IL-6 (H), and TNF-α (I) protein levels in the SDH at 12 h after gp120 injection. Box5 (10 μg), sFRP3 (2 μg) or vehicle was intrathecally administered 30 min prior to 100 ng of gp120 or vehicle injection. In summary graphs, the levels of target proteins were normalized against β-actin and expressed as relative units to the control (0 h or vehicle). Data presented in graphs are means ± S.E. from at least 3 mice per group from three experiments. *, p < 0.05; **, p < 0.01 versus control (one way ANOVA).
Capture Monoclonal Anti Murine Il 6 Antibody (Clone Mp5 20f3), supplied by Corning Life Sciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+il+6+capture+antibody/pm09581803-54-2-15?v=Corning+Life+Sciences
Average 90 stars, based on 1 article reviews
capture monoclonal anti-murine il-6 antibody (clone mp5-20f3) - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
Chimera Biotec GmbH anti-il6 capture antibody
Wnt5a is critical for gp120 to induce <t>IL-1β,</t> <t>IL-6,</t> and TNF-α in the SDH. A–C, time courses of IL-1β (A), IL-6 (B), and TNF-α (C) protein levels after i.t. gp120 (100 ng) administration. D–F, inhibition of Wnt5a by Box5 impaired gp120-induced increase of IL-1β (D), IL-6 (E), and TNF-α (F) protein in the SDH at 12 h after gp120 injection. G–I, sFRP3 attenuated gp120-induced increase of IL-1β (G), IL-6 (H), and TNF-α (I) protein levels in the SDH at 12 h after gp120 injection. Box5 (10 μg), sFRP3 (2 μg) or vehicle was intrathecally administered 30 min prior to 100 ng of gp120 or vehicle injection. In summary graphs, the levels of target proteins were normalized against β-actin and expressed as relative units to the control (0 h or vehicle). Data presented in graphs are means ± S.E. from at least 3 mice per group from three experiments. *, p < 0.05; **, p < 0.01 versus control (one way ANOVA).
Anti Il6 Capture Antibody, supplied by Chimera Biotec GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+il+6+capture+antibody/pm28483527-43-8-12?v=Chimera+Biotec+GmbH
Average 90 stars, based on 1 article reviews
anti-il6 capture antibody - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
PeproTech anti-cytokine capture antibody peprotech il-6
Wnt5a is critical for gp120 to induce <t>IL-1β,</t> <t>IL-6,</t> and TNF-α in the SDH. A–C, time courses of IL-1β (A), IL-6 (B), and TNF-α (C) protein levels after i.t. gp120 (100 ng) administration. D–F, inhibition of Wnt5a by Box5 impaired gp120-induced increase of IL-1β (D), IL-6 (E), and TNF-α (F) protein in the SDH at 12 h after gp120 injection. G–I, sFRP3 attenuated gp120-induced increase of IL-1β (G), IL-6 (H), and TNF-α (I) protein levels in the SDH at 12 h after gp120 injection. Box5 (10 μg), sFRP3 (2 μg) or vehicle was intrathecally administered 30 min prior to 100 ng of gp120 or vehicle injection. In summary graphs, the levels of target proteins were normalized against β-actin and expressed as relative units to the control (0 h or vehicle). Data presented in graphs are means ± S.E. from at least 3 mice per group from three experiments. *, p < 0.05; **, p < 0.01 versus control (one way ANOVA).
Anti Cytokine Capture Antibody Peprotech Il 6, supplied by PeproTech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+il+6+capture+antibody/pm26371858-65-10-13?v=PeproTech
Average 90 stars, based on 1 article reviews
anti-cytokine capture antibody peprotech il-6 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

N/A
This Antibody can be used as Capture in a human sandwich Immunoassay. The suggested coating concentration range should be optimised by each laboratory for each application.
  Buy from Supplier

Image Search Results


Wnt5a is critical for gp120 to induce IL-1β, IL-6, and TNF-α in the SDH. A–C, time courses of IL-1β (A), IL-6 (B), and TNF-α (C) protein levels after i.t. gp120 (100 ng) administration. D–F, inhibition of Wnt5a by Box5 impaired gp120-induced increase of IL-1β (D), IL-6 (E), and TNF-α (F) protein in the SDH at 12 h after gp120 injection. G–I, sFRP3 attenuated gp120-induced increase of IL-1β (G), IL-6 (H), and TNF-α (I) protein levels in the SDH at 12 h after gp120 injection. Box5 (10 μg), sFRP3 (2 μg) or vehicle was intrathecally administered 30 min prior to 100 ng of gp120 or vehicle injection. In summary graphs, the levels of target proteins were normalized against β-actin and expressed as relative units to the control (0 h or vehicle). Data presented in graphs are means ± S.E. from at least 3 mice per group from three experiments. *, p < 0.05; **, p < 0.01 versus control (one way ANOVA).

Journal: The Journal of Biological Chemistry

Article Title: Wingless-type Mammary Tumor Virus Integration Site Family, Member 5A (Wnt5a) Regulates Human Immunodeficiency Virus Type 1 (HIV-1) Envelope Glycoprotein 120 (gp120)-induced Expression of Pro-Inflammatory Cytokines via the Ca 2+ /Calmodulin-dependent Protein Kinase II (CaMKII) and c-Jun N-terminal Kinase (JNK) Signaling Pathways *

doi: 10.1074/jbc.M112.381046

Figure Lengend Snippet: Wnt5a is critical for gp120 to induce IL-1β, IL-6, and TNF-α in the SDH. A–C, time courses of IL-1β (A), IL-6 (B), and TNF-α (C) protein levels after i.t. gp120 (100 ng) administration. D–F, inhibition of Wnt5a by Box5 impaired gp120-induced increase of IL-1β (D), IL-6 (E), and TNF-α (F) protein in the SDH at 12 h after gp120 injection. G–I, sFRP3 attenuated gp120-induced increase of IL-1β (G), IL-6 (H), and TNF-α (I) protein levels in the SDH at 12 h after gp120 injection. Box5 (10 μg), sFRP3 (2 μg) or vehicle was intrathecally administered 30 min prior to 100 ng of gp120 or vehicle injection. In summary graphs, the levels of target proteins were normalized against β-actin and expressed as relative units to the control (0 h or vehicle). Data presented in graphs are means ± S.E. from at least 3 mice per group from three experiments. *, p < 0.05; **, p < 0.01 versus control (one way ANOVA).

Article Snippet: The primary antibodies used included: rabbit anti-Wnt5a (0.5 μg/ml; cat. 72583; abcam), rabbit anti-Wnt5a (1 μg/ml; cat. 2530; CST), goat anti-IL-1β (0.2 μg/ml; cat. AF-401-NA; R&D systems), rat-anti-IL-6 (0.5 μg/ml; cat. 554400; BD Biosciences), goat-anti-TNF-α (0.1 μg/ml; cat. AF-410-NA; R&D systems), rabbit anti-p-αCaMKII (Thr-286) (1:1000; cat. 3361; Cell Signaling Technology (CST)), rabbit anti-CaMKII (1:1000; cat. 3362; CST), rabbit anti-p-JNK (Thr-183/Tyr-185) (1:1000; cat. 9251; CST), rabbit anti-JNK (1:1000; cat. 9252; CST), rabbit anti-p-PKC (pan) (Thr-514) (1:1000; cat. 9379; CST), and rabbit anti-β-actin (1:1000; cat. 4967; CST) antibodies.

Techniques: Inhibition, Injection

Exogenous Wnt5a evokes the expression of IL-1β, IL-6, and TNF-α in the SDH. The time courses of IL-1β (A), IL-6 (B), and TNF-α (C) protein dynamics after i.t. Wnt5a (20 ng). In summary graphs, the levels of target proteins were normalized against β-actin and presented as relative units to 0 h. Data are expressed as means ± S.E. from at least three independent experiments with at least three animals. *, p < 0.05; **, p < 0.01 versus 0 h (one way ANOVA).

Journal: The Journal of Biological Chemistry

Article Title: Wingless-type Mammary Tumor Virus Integration Site Family, Member 5A (Wnt5a) Regulates Human Immunodeficiency Virus Type 1 (HIV-1) Envelope Glycoprotein 120 (gp120)-induced Expression of Pro-Inflammatory Cytokines via the Ca 2+ /Calmodulin-dependent Protein Kinase II (CaMKII) and c-Jun N-terminal Kinase (JNK) Signaling Pathways *

doi: 10.1074/jbc.M112.381046

Figure Lengend Snippet: Exogenous Wnt5a evokes the expression of IL-1β, IL-6, and TNF-α in the SDH. The time courses of IL-1β (A), IL-6 (B), and TNF-α (C) protein dynamics after i.t. Wnt5a (20 ng). In summary graphs, the levels of target proteins were normalized against β-actin and presented as relative units to 0 h. Data are expressed as means ± S.E. from at least three independent experiments with at least three animals. *, p < 0.05; **, p < 0.01 versus 0 h (one way ANOVA).

Article Snippet: The primary antibodies used included: rabbit anti-Wnt5a (0.5 μg/ml; cat. 72583; abcam), rabbit anti-Wnt5a (1 μg/ml; cat. 2530; CST), goat anti-IL-1β (0.2 μg/ml; cat. AF-401-NA; R&D systems), rat-anti-IL-6 (0.5 μg/ml; cat. 554400; BD Biosciences), goat-anti-TNF-α (0.1 μg/ml; cat. AF-410-NA; R&D systems), rabbit anti-p-αCaMKII (Thr-286) (1:1000; cat. 3361; Cell Signaling Technology (CST)), rabbit anti-CaMKII (1:1000; cat. 3362; CST), rabbit anti-p-JNK (Thr-183/Tyr-185) (1:1000; cat. 9251; CST), rabbit anti-JNK (1:1000; cat. 9252; CST), rabbit anti-p-PKC (pan) (Thr-514) (1:1000; cat. 9379; CST), and rabbit anti-β-actin (1:1000; cat. 4967; CST) antibodies.

Techniques: Expressing

Wnt5a/CaMKII and Wnt5a/JNK pathways differentially regulate the expression of IL-1β, IL-6, and TNF-α in the SDH. A and B, effects of KN-93 (KN) and SP600125 (SP) on i.t. Wnt5a-evoked pT286-αCaMKII (A) and pT183/Y185-JNK (B) in the SDH. C–E, effects of KN-93, SP600125, and stearoylcarnitine (ST) on Wnt5a-induced IL-1β (C), IL-6 (D), and TNF-α (E) in the SDH. F–H, effects of KN-93, SP600125, and stearoylcarnitine (ST) on gp120-induced IL-1β (F), IL-6 (G), and TNF-α (H) in the SDH. KN-93 (25 μg), SP600125 (10 μg), and ST (20 μg) were intrathecally administered 30 min prior to i.t. Wnt5a (20 ng) or gp120 (100 ng). At 12 h after Wnt5a, gp120 or vehicle injection, the SDH was collected. In summary graphs, the levels of target proteins were normalized with the β-actin loading control and expressed as relative units to the vehicle. Data in the graphs are presented as means ± S.E. *, p < 0.05; **, p < 0.01; ***, p < 0.001 (one way ANOVA).

Journal: The Journal of Biological Chemistry

Article Title: Wingless-type Mammary Tumor Virus Integration Site Family, Member 5A (Wnt5a) Regulates Human Immunodeficiency Virus Type 1 (HIV-1) Envelope Glycoprotein 120 (gp120)-induced Expression of Pro-Inflammatory Cytokines via the Ca 2+ /Calmodulin-dependent Protein Kinase II (CaMKII) and c-Jun N-terminal Kinase (JNK) Signaling Pathways *

doi: 10.1074/jbc.M112.381046

Figure Lengend Snippet: Wnt5a/CaMKII and Wnt5a/JNK pathways differentially regulate the expression of IL-1β, IL-6, and TNF-α in the SDH. A and B, effects of KN-93 (KN) and SP600125 (SP) on i.t. Wnt5a-evoked pT286-αCaMKII (A) and pT183/Y185-JNK (B) in the SDH. C–E, effects of KN-93, SP600125, and stearoylcarnitine (ST) on Wnt5a-induced IL-1β (C), IL-6 (D), and TNF-α (E) in the SDH. F–H, effects of KN-93, SP600125, and stearoylcarnitine (ST) on gp120-induced IL-1β (F), IL-6 (G), and TNF-α (H) in the SDH. KN-93 (25 μg), SP600125 (10 μg), and ST (20 μg) were intrathecally administered 30 min prior to i.t. Wnt5a (20 ng) or gp120 (100 ng). At 12 h after Wnt5a, gp120 or vehicle injection, the SDH was collected. In summary graphs, the levels of target proteins were normalized with the β-actin loading control and expressed as relative units to the vehicle. Data in the graphs are presented as means ± S.E. *, p < 0.05; **, p < 0.01; ***, p < 0.001 (one way ANOVA).

Article Snippet: The primary antibodies used included: rabbit anti-Wnt5a (0.5 μg/ml; cat. 72583; abcam), rabbit anti-Wnt5a (1 μg/ml; cat. 2530; CST), goat anti-IL-1β (0.2 μg/ml; cat. AF-401-NA; R&D systems), rat-anti-IL-6 (0.5 μg/ml; cat. 554400; BD Biosciences), goat-anti-TNF-α (0.1 μg/ml; cat. AF-410-NA; R&D systems), rabbit anti-p-αCaMKII (Thr-286) (1:1000; cat. 3361; Cell Signaling Technology (CST)), rabbit anti-CaMKII (1:1000; cat. 3362; CST), rabbit anti-p-JNK (Thr-183/Tyr-185) (1:1000; cat. 9251; CST), rabbit anti-JNK (1:1000; cat. 9252; CST), rabbit anti-p-PKC (pan) (Thr-514) (1:1000; cat. 9379; CST), and rabbit anti-β-actin (1:1000; cat. 4967; CST) antibodies.

Techniques: Expressing, Injection